Several studies have confirmed that reduced E-cadherin expression is significantly correlated with the poor prognosis of gastric cancer, hepatocellular cancer, lung cancer, head and neck squamous cell carcinoma, and breast cancer [5, 7, 9, 10, 33]. Here, CDH1 is linked to lung carcinoma.